申请人:Genentech, Inc.
公开号:US20170362228A1
公开(公告)日:2017-12-21
Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure:
and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
本文描述了具有雌激素受体调节活性或功能的四氢吡啶并[3,4-b]吲哚-1-基化合物,具有以下结构式:及其立体异构体、互变异构体或药学上可接受的盐,并具有此处描述的取代基和结构特征。还描述了包括该结构式化合物的药物组合物和药物,以及使用这种雌激素受体调节剂的方法,单独或与其他治疗剂联合使用,用于治疗通过雌激素受体介导或依赖的疾病或症状。